Anterior segment optical coherence tomography (AS-OCT) has become one of the cornerstones of non-contact imaging modalities for assessing such structures as the cornea, anterior chamber angle, aqueous outflow pathway, sclera, and ocular surface structures. As such, it has a broad range of clinical applications, which have been independently reported in the literature. This paper aims to present a review of extant literature on the utility of AS-OCT and its efficacy in clinical applications, and to evaluate the quality of available evidence. The following databases were searched from inception to 24 June 2018: Medline via Ovid, Cochrane Central Register of Controlled Trials, PubMed, World Health Organization International Clinical Trials Registry Platform, EMBASE, and CINAHL. Bibliographies of identified papers were hand searched. Inclusion criteria: articles describing or assessing the use of OCT for visualising the AS. The authors excluded studies without an identified primary outcome variable. One author independently selected studies, extracted data, and assessed for risk of bias using PRISMA guidelines. This review included 82 studies, of which there were 11 cohort studies, 37 case series, 10 case studies, 21 comparative observational studies, and three non-systematic review articles. Primary outcome variables included anterior chamber angle, angle opening distance, angle recess area, trabecular iris angle, trabeculairis space area, corneal thickness, tear meniscus height, tear meniscus area, tear meniscus volume, and the morphology of AS structures, including the ocular surface, blebs, flaps, and graft sites. This review attempts to encompass the breadth and depth of evidence for AS-OCT in the arena of diagnostics, therapeutics, and prognostics. At the same time, it brings to light the dearth of high-level evidence on this topic, suggesting the important role of randomised controlled trials and meta-analyses for the future validation of this technology.
Optical coherence tomography (OCT) is an excellent means of non-invasively imaging the eye using low coherence, broad bandwidth light. However, its traditional application is visualisation of the posterior segment. It was not until 1994 that the first account of anterior segment OCT (AS-OCT) was published. 1 Prior to this, ultrasound biomicroscopy was the primary means of assessing the AS. However, the image acquisition speed of ultrasound biomicroscopy is much slower than AS-OCT, at eight frames per second compared with 4,000 frames per second. 2 With the advent of AS-OCT, faster and more in-depth assessment of the anterior chamber has become possible.
OCT is an imaging modality that produces two-and three-dimensional cross-sectional imaging of tissue, by conglomerating multiple axial scans into a composite B-scan image. 2, 3 For AS imaging, it is advantageous to use a longer wavelength (1,050-1,310 nm) than retinal OCT (800-900 nm), due to the resultant minimisation in scattering and higher penetration. 4 This is important in visualising the structures in the vicinity of the iridocorneal angle, including the scleral spur and iris root. 5 The longer wavelengths of these machines do compromise image resolution to some extent, as shorter wavelengths afford superior axial resolution. 2 Earlier ASOCTs had axial resolutions in the range of 15-20 μm, which could not adequately image finer details of the AS such as Schwalbe's line and the trabecular meshwork. 5 Axial resolutions have since progressed to as high as 1-5 μm, 6 which are far superior to that offered by ultrasound biomicroscopy (35-70 μm).
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AS-OCT is not without its limitations. It falls short of Scheimflug analysis in terms of topographical delineation of the AS, and is inferior to ultrasound biomicroscopy for imaging structures past the iris pigment epithelium, as the infrared light that it utilises has poor penetration past this pigmented structure. 7 However, it is noted that a combined AS-OCT and Scheimflug camera device has been reported. 8 AS-OCT can be categorised into timedomain and frequency-domain OCT. In time-domain OCT, a moving reference mirror is used to obtain serial information about tissue reflectivity to infrared light, which in turn corresponds to tissue depth.
The Heidelberg slitlamp OCT also features a 1,310 nm wavelength, as well as a 15 mm scan width, and 7 mm scan depth. 10 Frequency-domain OCT can be further divided into Fourier-domain OCT, otherwise known as spectral-domain OCT, and sweptsource OCT. Spectral-domain OCT generates varying wavelengths of light to cause an interference pattern between the tissue sample of interest and the reference arm.
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A dispersive spectrometer is used to quantify this interference. 6, 12 Examples of spectral-domain OCT include the Spectralis (Heidelberg Engineering GmbH), RTVue (Optovue, Inc., Fremont, California, USA), and Cirrus OCT (Carl Zeiss Meditec). 5 As speed of image acquisition is not limited by the path length of a moving reference arm, the speed of acquisition of spectral-domain OCT surpasses that of time-domain OCT by 10 to 100 times. 2 Higher speed of acquisition also heightens image definition and reduces motion error. 2 Spectral-domain OCTs such as the RTVue which are designed to image both the anterior and posterior segments, use wavelengths as short as 830 nm. This has the advantage of high axial resolutions of 4-7 μm and a camera capture speed of 26,000 A-scans per second (13 times faster than the Visante). 2, 13 However, drawbacks do exist, such as lower horizontal scan widths (3-6 mm) and shorter scan depths. 9 Other variations of spectral-domain OCT are often custom-built designs with improved axial resolutions, termed 'ultrahigh-resolution OCT'. Reported axial resolutions of ultra-high-resolution OCTs range 14 μm, with scan widths of 5-12 mm. 14, 15 This degree of image resolution and definition enables visualisation of each layer of the cornea and conjunctiva, the tear film, meniscus and contact lens interfaces, [16] [17] [18] as well as the differentiation between benign and malignant ocular surface pathologies.
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The heightened resolutions are often achieved by installing broad bandwidth light sources exceeding 100 μm and spectrometers with superior sensitivities. 14 There are several commercially available ultra-highresolution OCTs, including the Copernicus HR (Optopol Technologies SA, Zawiercie, Poland) and Bioptigen Envisu (Bioptigen Inc., Morrisville, North Carolina, USA). 9, 22 A newer form of frequency-domain OCT, the swept-source OCT, has gained popularity in the last several years. It can be distinguished from spectral-domain OCT in several respects. First, the swept-source OCT is a 'swept laser', so named because it utilises a narrowband source to sweep across a broad optical bandwidth. 6 Instead of a spectrometer, swept-source OCT uses a semiconductor camera and two photodiode detectors. 9 These factors help to dramatically improve image acquisition speed, and to a lesser extent image resolution and the depth and breadth of scans. The DRI Triton swept-source OCT (Topcon, Tokyo, Japan) has a scan speed of 100,000 A-scans per second, a 1,050 nm wavelength, a horizontal scan width of 3-12 mm, and an axial resolution of 5 μm. 23, 24 An older form of swept-source OCT is the Casia SS-1000 OCT (Tomey, Nagoya, Japan), which features a scan speed of 30,000 A-scans per second, a 1,310 nm wavelength, horizontal scan width of 16 mm, and axial resolution of 10 μm. 9 Choma et al. have published data to suggest that swept-source OCT and spectral-domain OCT have comparable signal-to-noise ratio expressions. 6 Ultrafast versions of swept-source OCT and other forms of AS-OCT are now possible. 25 Finally, it is important to define the concept of en face OCT, which refers to the production of coronal scans (rather than axial scans), and can be generated by both frequency-domain OCT and spectraldomain OCT.
Methods

Study selection
One author independently screened all studies for eligibility. Multiple databases were consulted to source as many full-text articles as possible. Library requests were also lodged. If full-text publications could not be sourced, these publications were still included in the study, and were assessed based on their respective abstracts.
The following databases were searched from inception to 24 June 2018: Medline via Ovid, Cochrane Central Register of Controlled Trials, PubMed, EMBASE, and CINAHL. Database subject headings or MeSH terms were combined; there was no limit set on date of publication or publication type. Studies describing or assessing AS-OCT were included, although the authors excluded articles without a primary outcome measure. The authors handsearched the bibliographies of existing articles in their repository.
Data extraction
One author extracted data for all studies. Data extraction was performed using a standardised data extraction form, including information about participants, interventions comparisons, outcomes and results.
Measures of treatment effect
As the included studies were a mix of quantitative and qualitative outcome variables, it was impractical to measure treatment effect either in terms of risk ratios or mean differences. Due to the lack of randomised controlled trials, the included studies lacked blinding of intervention or concealment of allocation. In most studies, selective reporting could not be excluded. Sensitivity analysis to account for the impact of excluded studies was not conducted due to the lack of sufficient numbers for each outcome variable.
Results
This review included 82 studies, of which there were 11 cohort studies, 37 case series, 10 case studies, 21 comparative observational studies, and three nonsystematic review articles. Of the review articles, two reviewed level III evidence and below, while one included level II evidence, but only level III evidence in relation to AS-OCT. There were no randomised controlled trials that fulfilled the inclusion criteria. The authors identified six clinical trials registered on the World Health Organization International Clinical Trials Registry Platform, but were unable to source the data for these trials.
Participants included healthy subjects as well as those with various ocular pathologies, who were undergoing or who had undergone AS-OCT. There were no restrictions imposed on the intervention or comparators in included studies, as many were non-comparative in nature; however, several studies did compare AS-OCT with ultrasound biomicroscopy. The included outcomes were various, including: angle opening distance at 250, 500, and 750 μm from the scleral spur, angle recess area, trabecular iris angle, trabecular-iris space area, corneal thickness, tear meniscus height, tear Clinical and Experimental Optometry 102.3 May 2019meniscus area, tear meniscus volume, appearance of ocular surface neoplasia, pterygia, conjunctival graft thickness, bleb and flap morphology, and stromal bed thickness after laser-assisted in situ keratomileusis. Length of follow up varied from nil to 18 months. One study (Izatt et al.) was performed on animals.
1 All other studies were performed on human subjects. See Table 1 for a summary of the included studies in this review.
Tear meniscus
AS-OCT visualisation of the tear film is particularly useful in the assessment of dry eye syndrome, epiphora, and punctal occlusion, as well as in the monitoring of therapeutic responses for these pathologies. [26] [27] [28] For instance, spectral-domain OCT has been employed by Bujak et al. to document changes in the tear meniscus after the use of artificial tears. 26 In patients with epiphora, AS-OCT can document a fall in tear meniscus height after dacryocystorhinostomy or four-snip punctoplasty. 29, 30 There are also some evidence that AS-OCT may also be applied in direct Meibomian gland assessment, with Hwang et al. using a variant of spectral-domain OCT to produce three-dimensional images of these glands. 28 In most studies, tear meniscus can be quantified by AS-OCT in terms of tear meniscus height, tear meniscus depth, and tear meniscus area, measured directly after blinking. 31 This enables a myriad of experimental data to be generated; for instance Sizmaz et al. have shown that patients with Graves' disease have lower tear meniscus height. 32 The application of AS-OCT in tear film analysis is perhaps most relevant in the assessment of aqueous tear-deficient dry eye syndrome, for which the gold standard test, the Schirmer test, is very dependent on patient co-operation and may not be tolerated by patients due to discomfort. Nguyen et al. reported that tear meniscus height, depth, area, and angle, as quantified by AS-OCT, demonstrated good agreement with self-reported symptoms. 33 
Conjunctiva
Conjunctival pathologies that may benefit from AS-OCT assessment are numerous. In patients with conjunctivochalasis, AS-OCT is able to image the cross-sectional area of conjunctival prolapse onto tear meniscus. 34 In pterygium and pinguecula, spectraldomain OCT can visualise these growths in minuscule detail, as subepithelial hyperreflective wedge-shaped masses with a thin overlying epithelium above Bowman's membrane. 35 Nanji et al. reported similar findings using ultra-high-resolution OCT. 36 AS-OCT is also able to distinguish between pterygium, pseudopterygium (in which the overlying membrane remains detached from the cornea), 4 and pinguecula (in which the overgrowth terminates at the limbus). 35 AS-OCT is useful in tracking post-operative changes following conjunctival autograft and pinguecula argon photocoagulation. 37, 38 AS-OCT may be valuable for predicting intraoperative and post-operative complications, such as corneal opacity, scleral thinning, or scleromalacia. 4 For those cases of scleromalacia that require grafting or even amniotic-membrane transplantation, AS-OCT can be employed in estimating the thickness of the residual stromal bed. 4 Cornea Figure 1 depicts a normal AS (top) and swollen left cornea following an episode of acute angle closure glaucoma (bottom), as visualised by AS-OCT.
REFRACTIVE SURGERY
AS-OCT has a broad utility in this field, both during and after cataract and laser in situ keratomileusis surgery, and to prevent and monitor post-operative ectasia resulting from the latter. There are several reports of the utilisation of AS-OCT to visualise cataract clear corneal incisions. 39, 40 AS-OCT can quantify the depth of external incision, the angle between corneal surfaces, and both the curvilinear and linear lengths between internal and external wounds. 39 AS-OCT can also detect postoperative complications such as Descemet's membrane detachment, or gaping and misalignment of the corneal endothelium. 4 In terms of crystalline lens imaging, Nagy et al. used AS-OCT to image the lens changes after femtosecond cataract surgery, specifically capsulorrhexis and fragmentation of the nucleus. 41 Kymionis et al. have published data on the ability of AS-OCT to show posterior capsular rent in using femtosecond laser. 42 In terms of laser-assisted in situ keratomileusis, spectral-domain OCT and ultrahigh-resolution OCT have been reported to offer detailed imaging of the thickness of the created flap and remaining stromal bed. 43, 44 Li et al. were able to utilise AS-OCT to image 100 per cent of laserassisted in situ keratomileusis flap boundaries and thicknesses at one day and one week post-operatively. 39 They propose that the one week post-operative time point is optimal, as it allows good recovery from iatrogenic changes to the corneal structure. The ability of AS-OCT to visualise flaps decreased over time, to 61 per cent of flap boundaries at three months and 42 per cent at six months, although the assessment of flap thickness was not affected by time. 39 Shetty et al. have reported effective use of intraoperative hand-held spectraldomain OCT (Bioptigen Inc.) to assess laser-assisted in situ keratomileusis flaps, prior to the development of flap oedema and stromal bed hydration. 45 However, spectral-domain OCT can also be used for quantitative assessment of this post-laserassisted in situ keratomileusis corneal inflammation and oedema. 46 Han et al. have used spectral-domain OCT to detect signs of interface fluid syndrome, including interface haze and flap oedema, which is a complication of laser-assisted in situ keratomileusis surgery. 47 KERATOCONUS AS-OCT can be employed in pachymetry to detect ectasias, whether iatrogenic or otherwise in aetiology. Li et al. have published a set of parameters whereby ectasia, and specifically keratoconus, may be quantified. The criteria assess the central 5 mm diameter of the pachymetry map in terms of: (1) I-S (average thickness of the inferior OCTant minus thickness of the superior OCTant) > 31 μm; (2) IT-SN (inferotemporal OCTant thickness minus superonasal OCTant) > 48 μm; (3) minimum thickness < 492 μm; (4) minimum-maximum thickness < −63 μm; and (5) thinnest part of the cornea lies beyond the central 2 mm. 48 They
propose that a definitive diagnosis of keratoconus can be made if more than one of the above criteria are fulfilled. 48 AS-OCT proves particularly advantageous in the detection of subclinical keratoconus, in which patients present with unimpaired visual acuity and stable corneal topography. 2 The recognition of keratoconus, corneal thinning, and ectasia, are in turn important in the assessment of patient suitability for refractive laser surgery. Ring segments can also be inserted deep into the corneal stroma to correct corneal curvature in keratoconus. AS-OCT can determine the position of the ring segments during implantation, and prevent unwanted complications, including anterior chamber perforation or epithelial-stromal breakdown. 9, 54 CORNEAL TRANSPLANTATION Pre-operatively, AS-OCT can be employed to assess the thickness and preservation potential of the graft tissue. 55 Intraoperatively, in deep anterior lamellar keratoplasty, AS-OCT can help to determine depth of dissection. 56 In the big-bubble technique, AS-OCT can visualise the depth of pneumatic dissection to determine the necessity for air injection. 57 As AS-OCT becomes increasingly more sophisticated in its image resolution, it may also be adopted to screen candidates for eye banking. 7 Lim et al. have demonstrated that AS-OCT may be important in deep anterior lamellar keratoplasty in detecting issues with graft apposition and identifying Descemet's membrane detachment. 58 Lim et al. also published data on the use of AS-OCT in detecting complications after Descemet's stripping automated endothelial keratoplasty and Descemet's membrane endothelial keratoplasty. These include corneal oedema, graft dislocation of failure, anterior chamber angle narrowing, and pupillary block. 59 In the absence of AS-OCT, slitlamp examination alone may miss Descemet's membrane detachment in cases of corneal oedema. 4, 60 Moreover, AS-OCT can precisely characterise detachments in terms of extent and planarity, and identify cases of membrane rupture. 4 More recently, Satue et al. also demonstrated that swept-source OCT is a reliable detector of early graft detachment after Descemet's membrane endothelial keratoplasty. 61 AS-OCT may be used to predict Descemet's stripping automated endothelial keratoplasty graft failure by elucidating the presence of residual host membrane tissue at the graft. 62 Miyakoshi et al. have also proposed AS-OCT as a means of detecting fluid between the host-donor interface in Descemet's stripping automated endothelial keratoplasty. 63 Knecht et al. have reported on the use of hand-held AS-OCT for this purpose. 59 Figure 2 shows a normal postoperative day one corneal endothelial graft following Descemet's membrane endothelial keratoplasty (A) and Descemet's membrane endothelial keratoplasty graft not correctly apposed to the posterior corneal stroma (B).
The best time to conduct AS-OCT for the prediction of graft success and failure is uncertain. Yeh et al. suggest that in order to best predict graft adherence status at six months, the optimal time to image the graft site with AS-OCT is one hour postoperatively. 64 In contrast, Shih et al. reported that one week post-operative assessment of corneal thickness has good predictive value for Descemet's stripping automated endothelial keratoplasty.
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CORNEAL DYSTROPHY
In patients with granular corneal dystrophy requiring removal of stromal haze, spectraldomain OCT is a useful means of determining keratectomy depth.
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Ultra-highresolution OCT can also be utilised to visualise Fuchs' dystrophy. Shousha et al. showed that in patients with Fuchs' dystrophy, AS-OCT quantification of Descemet's membrane thickness has good correlation with that of light microscopy. 9, 15 Ang et al. have explored the concept of a micro-OCT, which features a conical scan pattern that can attain a spatial resolution of 1-2 μm in vitro. 8 This may enable imaging of corneal cells. 8 However, the trade-off is a lower depth and breadth of field, slower scan speed, and susceptibility to movement artefact. 8 Sclera Figure 3 shows a normal anterior sclera as visualised by Watson et al., who were able to use AS-OCT to visualise deep scleral layers and the suprachoroidal space. 68 They also utilised the RTVue OCT and a custom-built en face AS-OCT to differentiate between different forms of nodular scleritis through visualisation of scleral collagen fibres.
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Spectral-domain OCT has also been used to identify and monitor treatment response in a case of tuberculous nodular episcleritis. 69 AS-OCT may prove useful in the differentiation between scleritis and episcleritis. Shoughy et al. have published findings on the appearance of anterior scleritis on AS-OCT compared with that of episcleritis and normal controls. characterised by scleral thickening (882 μm compared with 825 μm in episcleritis and 750 μm in normal controls), although tests of significance were not performed on these mean values. 70 However, the study concluded that scleral thickness alone can be confounded by anatomical variants such as nodular scleritis, and that the presence of oedema, manifesting as areas of hyporeflection on AS-OCT, was the most important criterion in the diagnosis of scleritis. 70 Levison et al. used spectral-domain OCT to delineate other characteristic features of scleritis, including deep episcleral vessel dilation and differences in tissue reflectivity. 71 Axmann et al. have also reported that dilated episcleral vessels are found in both scleritis and episcleritis, but note that AS-OCT is valuable in visualising deep episcleral vessel dilatation, which is more suggestive of scleritis.
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Anterior chamber angle
As opposed to the poor reproducibility of gonioscopy, the non-contact nature of OCT means that there is no mechanical distortion of the angle, which improves the reliability of the angle depth measurement. 73 However, the area beyond the iris pigment epithelium is generally impermeable to infrared light; consequently, AS-OCT has limited application in imaging the ciliary sulcus or posterior ciliary body. 74 The association between angle closure and shallow anterior chamber depth is well known. AS-OCT has been utilised to image possible associated anatomical features, in particular iris bowing anteriorly and pupillary block. 78 Matsuki et al. used AS-OCT on a Japanese sample to analyse the links between iris thickness, iris convexity, and angle narrowing. 78 They proposed that increased iris convexity is associated with decreased iris thickness, which suggests how conditions such as relative pupillary block can stretch the iris forward, contributing to angle closure. 78 This is supported by data from Hirose et al. 79 Other than medical management, laser peripheral iridotomy is often a first line procedural management of acute angle closure. Lee et al. have reported that AS-OCT can be used to monitor changes to the anterior chamber angle after laser iridotomy. 68 
TRABECULECTOMY
If medical and procedural interventions for progressive glaucoma are exhausted, trabeculectomy is a surgical option available to select patients. AS-OCT has been used to visualise the structure of filtering blebs. 80, 81 Guthoff et al. demonstrated the use of AS-OCT in selecting blebs for needling and analysis after laser suture lysis. 82, 83 Kim et al. showed AS-OCT can be implemented in surgically correcting overhanging filtering blebs. 84 AS-OCT can also be used to monitor filtering blebs and tubes in the early postoperative stage.
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SECONDARY ANGLE CLOSURE Angle closure may be secondary to a myriad of secondary factors, such as congenital syndromes like pigment dispersion syndrome, lens intumescence (phacomorphic glaucoma, see Figure 4 ), or iatrogenic (such as those due to laser peripheral iridotomy or glaucoma surgery).
PLATEAU IRIS SYNDROME AS-OCT can be applied in the monitoring of patients post-laser iridotomy, especially in those in whom the angle fails to open postprocedure. This is a condition termed plateau iris syndrome. In these patients, laser peripheral iridoplasty may be used as a second attempt to resolve the angle closure. 86 Ramakrishnan et al. demonstrated that AS-OCT is an effective imaging modality for characterising the angle pre-and postprocedure in such cases. 86 
AQUEOUS MISDIRECTION
Aqueous misdirection most commonly manifests as an iatrogenic phenomenon following surgical interventions for glaucoma. It is also known as malignant glaucoma, ciliary block glaucoma, or lens block glaucoma. The condition is thought to involve aqueous flow into the posterior segment. As such, this is a rare instance in which ultrasound biomicroscopy may be superior to AS-OCT, as part of the anatomical culprits for aqueous misdirection lie deep into the iris, near the ciliary body. 85 Nevertheless, Wirbelauer et al. have published a case study on the application of slitlamp-adapted AS-OCT for two patients who underwent surgery for primary open angle glaucoma, and who subsequently developed aqueous misdirection. 87 Imaging was conducted both during the acute episode, as well as post-pars plana vitrectomy and viscoelastic reformation of the anterior chamber. 87 AS-OCT was able to quantify the increase in depth of the anterior chamber and increase in the angle, as measured by angle opening distance and anterior chamber angle.
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PIGMENT DISPERSION SYNDROME AS-OCT may be pertinent in the assessment of pigment dispersion syndrome, and in the evaluation of potential candidates for Nd: YAG laser iridotomy, which may help to correct the condition. Shah et al. have demonstrated good inter-and intra-observer
Iris
Lens
Pupil block Narrow angle agreement in the use of AS-OCT to delineate the iris profile in these patients. 88 In a separate study, Shah et al. have reported on the associations between iris concavity and various AS parameters identified on AS-OCT, including lens vault, anterior chamber depth, and mean scleral spur angle. 89 Individuals with pigment dispersion syndrome are thought to have a genetic predisposition for the condition. However, iatrogenic cases have also been reported. For instance, Cabrera et al. published a case study on the use of AS-OCT to monitor pigmentary glaucoma secondary to collamer lens implantation. 90 Aqueous outflow pathway 92 Studies from 2016 also demonstrated that the size of Schlemm's canal increased in patients post-canaloplasty, an increase that correlated with a decrease in intraocular pressure.
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Tumours
Literature suggests that in comparison with ultrasound biomicroscopy, AS-OCT may lack the penetration to properly visualise pigmented tumours of the iris and ciliary body, particularly those that are larger in size. 96 Thus, the utility of AS-OCT in tumour visualisation lies primarily in the domain of small non-pigmented anterior iris tumours and lesions of the ocular surface. 96, 97 Indeed, Krema et al. showed ultrasound biomicroscopy was able to adequately visualise all posterior surface tumours, but only 54 per cent were detected by AS-OCT. 96 Biancotto et al. reported that AS-OCT was able to detect tumour margins in 40 per cent of cases (n = 200), and posterior tumour shadowing in only five per cent of cases, as compared with 95 and 72 per cent of cases by ultrasound biomicroscopy. 98 In ocular surface squamous neoplasia, spectral-domain OCT and ultra-high-resolution OCT show a thick and hyper-reflective epithelium. 22, 36 With resolution of ocular surface squamous neoplasia, ultra-high-resolution OCT images can demonstrate progression toward epithelial normalisation: reduced thickness and hyperreflectivity with more graduated transition zones. 22 In patients with conjunctival lymphoma, Nanji et al. demonstrated that spectraldomain OCT is able to characterise the pathology as a hyporeflective lesion with a surrounding layer of hyper-reflective subepithelia. 36 Spectral-domain OCT is able to visualise epithelial hyper-reflectivity, particularly in the basal layer, of nevi and melanoma. 36 In melanoma, it can detect the distinguishing intense shadow cast by tissue below this area. 36 It is also able to show presence of intralesional cystic spaces in nevi, which can be used to distinguish between benign and malignant lesions. 21 Thomas et al. have reported similar findings with ultra-high-resolution OCT. 22 Nanji et al. have used ultra-highresolution OCT to characterise Salzmann nodular degeneration, which appears as a hyper-reflective thick subepithelial lesion above Bowman's layer, surrounded by normal epithelial tissue. 36 
Conclusion and future directions
Over the last two decades, AS-OCT has advanced from a potential imaging modality for the AS, to take a firm role at the forefront of diagnostic and therapeutic monitoring of corneal, conjunctival, scleral, and other ocular surface pathologies, and in the assessment of glaucoma.
This review demonstrates that with each new generation of AS-OCT, the degree of image depth, resolution, and acquisition speed reaches new heights. AS-OCT technology is now able to transcend the anatomical assessment of the AS to physiological properties such as ocular tissue biomechanics. OCT elastography has been used by Kirby et al. and Zaitsev et al. to analyse tissue movement and velocity in response to forces, such as in laser corneal reshaping. 99, 100 It has been proposed that the future trajectory of AS-OCT is to provide an 'optical biopsy' of ocular structures, once it becomes capable of imaging the anatomical intricacies of nerves, vessels, and organisms at the cellular level. 2 This may not be far from becoming reality, with the advent of microscope-integrated OCT, three-dimensional OCT, and OCT angiography. 
Potential biases in the review process
This study did not assess heterogeneity, either based on the similarity of the population, intervention, outcome, or follow-up. Due to the dearth of available high-level evidence, the authors did not present funnel plots to evaluate selective publication, or sensitivity analyses to detect the impact of excluded studies. This paper would have benefitted from independent screening of available evidence by multiple authors. The range of available evidence may have been broadened by contacting the authors of potentially eligible conference abstracts, to trace full-text publications of these studies, and by contacting authors of included studies to request further information concerning missing data, and withdrawn study participants.
